Status:
COMPLETED
A Study to Evaluate Effectiveness and Safety of Hyaluronic Acid (HA) Fillers
Lead Sponsor:
Galderma R&D
Conditions:
Volume Deficiency of the Midface
Eligibility:
All Genders
25-55 years
Phase:
NA
Brief Summary
The purpose of the study is to investigate the degree of improvement in appearance after treatment with different hyaluronic acid (HA) fillers. Product selection is based on Investigator assessment of...
Eligibility Criteria
Inclusion
- Male/Female 25 to 55 years old that needs lifting, contouring or volumization of the midface
- Signed and dated informed consent
Exclusion
- Known/previous allergy or hypersensitivity to any injectable hyaluronic acid (HA) gel and lidocain
- Previous use of any permanent or semi-permanent facial tissue augmentation therapy or contouring with, lifting threads, permanent implants, or autologous fat in the treatment area
- Previous use of any HA or collagen based facial tissue augmentation therapy in the facial area, any previous use of neurotoxin or any previous facial surgery
- Any medical condition that in the opinion of the Investigator would make the participant unsuitable for inclusion
Key Trial Info
Start Date :
November 9 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2019
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03869450
Start Date
November 9 2018
End Date
August 30 2019
Last Update
August 26 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Galderma Research Site
Munich, Germany, 80636
2
Galderma Research Site
Palermo, Italy, 90141
3
Galderma Research Site
Edinburgh, United Kingdom, EH10 4BE